Evaluation of Green Tea for Improving Blood Lipid Profile
NCT ID: NCT06992765
Last Updated: 2025-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
38 participants
INTERVENTIONAL
2023-03-15
2025-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combination Treatment With Green Tea Extract and Statins in Patients With Hypercholesterolemia
NCT00944827
Ginger and Plasma Cholesterol Efflux Capacity
NCT06662695
Long-term Effectiveness Study on Cholesterol-reducing Activity
NCT01521169
The Effectiveness of Plant Stanols as Ester on Change in Blood Cholesterol Level
NCT02779673
China Plant Sterol Trial
NCT00145717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
2 bottles of light green tea daily containing totally 108 mg of catechin
Placebo
2 bottles of light green tea daily containing totally 108 mg of catechin
Intervention
2 bottles of light green tea daily containing totally 684 mg of catechin
Intervention
2 bottles of light green tea daily containing totally 684 mg of catechin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
2 bottles of light green tea daily containing totally 684 mg of catechin
Placebo
2 bottles of light green tea daily containing totally 108 mg of catechin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Those who have been assessed as dyslipidemia by a family physician but have not yet required medication. The following measurement values were used as evaluation criteria:
1. Hypercholesterolemia: plasma total cholesterol (TC) \>200 mg/dL;
2. Mixed hyperlipidemia: plasma total cholesterol (TC) \>200 mg/dL , triglyceride (TG) \>200 mg/dL;
3. Hypertriglyceridemia: plasma triglyceride (TG) \>200 mg/dL, and high-density lipoprotein cholesterol (HDL-C) \< 35 mg/dL or TC/HDL-C \>5.
Exclusion Criteria
* Take any drugs or supplements that can affect blood lipid levels 2 weeks before or during the experiment.
* People with intolerance to caffeine or green tea.
* People who take drugs for chronic diseases.
* People who smoke or drink alcohol.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eagletek Corp.
UNKNOWN
Taipei Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Medical University
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
lin5611_2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.